Profil
Nicholas Vlahakis worked as the Chief Medical Officer at CohBar, Inc. in 2022-2023.
Prior to that, he was the Vice President & Head of Clinical Development at Global Blood Therapeutics, Inc. and the Vice President & Head of Respiratory Disease at Unity Biotechnology, Inc. Mr. Vlahakis holds a doctorate degree from the University of Adelaide.
Ehemalige bekannte Positionen von Nicholas Vlahakis
| Unternehmen | Position | Ende |
|---|---|---|
| COHBAR, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Nicholas Vlahakis
| University of Adelaide | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |